Market Research Report
Europe Drug Discovery Market Forecast 2019-2027
|Published by||Inkwood Research||Product code||609208|
|Published||Content info||92 Pages
Delivery time: 2-3 business days
|Europe Drug Discovery Market Forecast 2019-2027|
|Published: August 12, 2019||Content info: 92 Pages||
The European drug discovery market is projected to rise with a CAGR of 8.22% during the forecast years of 2019-2027. By the end of 2027, the Europe market is expected to reach a worth of $XX million and capture XX% market share in the global drug discovery market. The European healthcare market is equipped with comprehensive and updated technology, which showcase tremendous growth potential for the drug discovery market.
The European drug discovery market is mainly influenced by the contributing countries such as France, Germany, Italy, Spain, and the United Kingdom. The report also analyzed the Rest of Europe regional segment that is formed by a conglomeration of other remaining countries. The healthcare spending of European countries is increasing considerably. Also, as the incidences of chronic diseases are rising in the region, which leads to surging demand for specialty medicines, in turn, fueling drug discovery market growth. In addition, implementation of drug discovery programs across the European countries is boosting the market demand. However, stringent government regulations delaying the processes for product launches could significantly restrain the market growth.
Novartis, Johnson and Johnson, Merck & Co. Inc., Pfizer Inc., GlaxoSmithKline LLC, and Sanofi, are few of the renowned players operating in the drug discovery market. The market is highly competitive due to the presence of giant multinational companies. However, the new entrants face the entry-level barrier due to the high capital requirement for research & development of new drugs.